TELANasdaq

TELA Bio, Inc.

Surgical & Medical Instruments & Apparatus · DE · CIK 1561921

TELA Bio provides soft-tissue reconstruction solutions that optimize outcomes by preserving and restoring patient anatomy

red 8-K · 90d

+ Watch View on EDGAR ↗

$32M

Market cap

$0.85

Last close

-1.3%

+17.4%

67K

Volume

Price$0.85-59.1%· 1Y

Volume

Jul 10L $0.56 · H $2.13Jul 10

Revenue & earnings

RevenueNet incomeLoss

Fundamentals & quality

Trailing fundamentals · via Polygon & SEC

Rev growth YoY

15.8%

Trailing 12 months

Gross margin

67.7%

Gross profit / revenue

Net margin

-49.3%

Net income / revenue

ROE

-615.1%

Return on equity

ROIC

-42.0%

Return on invested capital

FCF yield

-88.8%

Free cash flow / mkt cap

P/E

—

Price / earnings

P/S

0.4

Price / sales

Similar companies

Comparable business profile · signals at a glance

SMTISanara MedTech Inc.$227.6M-0.3%AXGNAxogen, Inc.$2.4B-7.0%MDXGMIMEDX GROUP, INC.$588.3M-0.7%AORTARTIVION, INC.$1.2B-0.1%ESTAESTABLISHMENT LABS HOLDINGS INC.

Filings archive

Newest first · each with a one-line AI read · showing 10 of 155

Jun 11, 20268-KExecutive Change · Shareholder VoteTELA Bio, Inc. stockholders approved an amendment to the 2019 Equity Incentive Plan to increase authorized shares by 3,500,000. Stockholders also elected directors and ratified the independent registered public accounting firm.Jun 9, 2026SC 13DSC 13D May 13, 202610-Q10-QTELA Bio, Inc. reported a net loss of $12.3 million for the first quarter of 2026, an increase from the $11.3 million net loss in the same period of 2025. Revenue grew slightly to $19.1 million, driven by international sales, but gross margin decreased due to higher inventory costs. The company believes its current cash of $39.5 million is sufficient for at least the next 12 months, supported by a $60 million credit facility.

Insider activity

Open-market buys & sells (Form 4) · trailing 12 months

1 bought · 0 sold

Net insider $ · by month

2025-11buys ▲ · sells ▼2025-11

Ew Healthcare Partners Fund 2-Ugp, Llc

TenPercentOwner,Other

Bought$4.0M

1 buy

Open-market buys & sells (Form 4, transaction codes P/S), aggregated per insider over the trailing 12 months. Source: SEC structured insider data.